{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/management/management-of-superficial-vein-thrombosis/","result":{"pageContext":{"chapter":{"id":"b2e8f26a-d211-5c11-8c71-c772eea8dde7","slug":"management-of-superficial-vein-thrombosis","fullItemName":"Scenario: Management of superficial vein thrombosis","depth":2,"htmlHeader":"<!-- begin field 9818ce6d-2104-447c-8515-bce127ccd3e3 --><h2>Scenario: Management of superficial vein thrombosis </h2><!-- end field 9818ce6d-2104-447c-8515-bce127ccd3e3 -->","summary":"Covers the management of people with superficial vein thrombosis.","htmlStringContent":"<!-- begin item 05d8ebff-dc2a-430b-aade-ca9c1789ec00 --><!-- begin field 514224f1-4423-442c-970c-acbc01583d4b --><p>From age 16 years onwards.</p><!-- end field 514224f1-4423-442c-970c-acbc01583d4b --><!-- end item 05d8ebff-dc2a-430b-aade-ca9c1789ec00 -->","topic":{"id":"07820562-ab2f-5ea0-9097-3e6e5a62bec4","topicId":"3c0e3637-8623-4aa4-9bdf-83c4ead61135","topicName":"Superficial vein thrombosis (superficial thrombophlebitis)","slug":"superficial-vein-thrombosis-superficial-thrombophlebitis","lastRevised":"Last revised in March 2020","chapters":[{"id":"a5f3a42e-3e23-59d7-83fb-fd26995ebf74","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1ceec510-5b3b-59b2-be08-fde928defc1e","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"8b0cc395-7b80-5e19-a891-b27b1d88c9f3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"75c7c081-3b2a-5f62-aead-766ba5534a36","slug":"changes","fullItemName":"Changes"},{"id":"fcc6e0b2-bfab-56d2-a1e0-57e5f3f6c19a","slug":"update","fullItemName":"Update"}]},{"id":"6da7aa90-c506-5e57-baed-74b22c09af0a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8a802f98-487d-5c7e-829e-4a9e669fe875","slug":"goals","fullItemName":"Goals"},{"id":"7dff5216-bc4a-529e-854f-a128cb8b54ca","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"999e411a-0346-5c64-aa2d-eba133633715","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"fed9fa0e-2eb0-5385-b244-1efe9fad43ce","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"58585f51-d63a-5cf7-bd5e-f14b6dd9c02a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"62ad8730-5197-5854-acff-ffd86c7f8b92","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5d82d4b3-7ef8-52e7-a668-a65cc11d7bf7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"63f70d2c-b895-556e-8108-242a922f573d","slug":"definition","fullItemName":"Definition"},{"id":"8bfc3751-dc6d-58d5-9548-38ebf176bc48","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"8b1679ef-efa4-5e5e-8690-815334d03623","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b23bb9bc-355d-5db3-909c-ba53a4e4ed95","slug":"complications","fullItemName":"Complications"},{"id":"898b7fad-5295-5eef-991c-921d6b584b9c","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a7a8c85c-9ce4-5f12-a1f5-23a4ebba755d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"f7b2717f-67b0-51d3-802e-6289738de5fd","slug":"assessment","fullItemName":"Assessment"},{"id":"c4ead320-38b8-564e-b12e-14547b74132b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"feb9b5f1-73aa-5b36-adca-1c0cf461f9fa","fullItemName":"Management","slug":"management","subChapters":[{"id":"b2e8f26a-d211-5c11-8c71-c772eea8dde7","slug":"management-of-superficial-vein-thrombosis","fullItemName":"Scenario: Management of superficial vein thrombosis"}]},{"id":"ce1a244a-7eef-554a-b0fd-97c7358b1c5a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"98221bb6-71ac-5332-8985-2100a5306385","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3b6f9e44-2ba1-5f2a-a188-d838e155e461","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"21be8a1b-6557-5a82-8b2c-b0e11bd94c6f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"71a14a91-6970-576c-a048-a5e79a477304","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f6bee233-b8a0-577f-874c-2612e21a7dff","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"fd0ecbc9-ffa5-52d9-839e-435308bda796","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ccd8f8d7-dbcb-5110-ba6c-fe88bca09f07","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"feb9b5f1-73aa-5b36-adca-1c0cf461f9fa","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"2773842b-17b7-52de-950f-1713cc97c393","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 97886029-d943-41dc-b6a0-fa4b7dbdd0b0 --><h3>How should I manage a person with superficial vein thrombosis?</h3><!-- end field 97886029-d943-41dc-b6a0-fa4b7dbdd0b0 -->","summary":null,"htmlStringContent":"<!-- begin item 006383ab-3443-4628-8e77-f0b9c19d6b50 --><!-- begin field e1991cb3-b9de-4280-83d1-0adf7b2d8235 --><ul><li><strong>If deep vein thrombosis (DVT) or pulmonary embolism (PE) is suspected:</strong><ul><li>See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/deep-vein-thrombosis/\">Deep vein thrombosis</a> and <a class=\"topic-reference external-reference\" href=\"/topics/pulmonary-embolism/\">Pulmonary embolism</a> for management information.</li></ul></li><li><strong>If the person has varicose veins or a venous leg ulcer:</strong><ul><li> See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/varicose-veins/\">Varicose veins</a> and <a class=\"topic-reference external-reference\" href=\"/topics/leg-ulcer-venous/\">Leg ulcer - venous</a> for management information.</li></ul></li><li><strong>If a serious <a class=\"topic-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/background-information/causes-risk-factors/\">underlying cause</a> of superficial vein thrombosis, such as cancer, is suspected:</strong><ul><li>Refer appropriately for specialist assessment.</li></ul></li><li><strong>For all other people with superficial vein thrombosis:</strong><ul><li><strong>Treat pain with a simple analgesic.</strong><ul><li>Prescribe an oral nonsteroidal anti-inflammatory drug (NSAID) and/or paracetamol. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a> and <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> for prescribing information.</li><li>Consider a topical NSAID for mild and limited superficial vein thrombosis.</li><li>Continue treatment until pain settles (usually within 1–2 weeks, although the thrombosed vein may be palpable and tender for several weeks to months).</li></ul></li><li><strong>Give self-care advice to relieve symptoms and reduce the risk of <a class=\"topic-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/background-information/complications/\">complications</a>. </strong>Advise that:<ul><li>A warm, moist towel or flannel applied to the affected limb may provide symptomatic relief.</li><li>Keeping the leg elevated when sitting may improve venous blood flow and reduce swelling.</li><li>They should continue using the affected limb and remain mobile in order to reduce the risk of DVT. </li></ul></li><li><strong>Be aware that antibiotics are not indicated unless there are signs of infection</strong> (such as high fever and malaise).<ul><li>If there are signs of infection, consider arranging hospital admission, especially if the person is at risk of complications because they are frail, elderly, immunocompromised, or have an indwelling intravenous catheter.</li></ul></li><li><strong>Consider referral to a vascular service</strong> for venous duplex scanning to help guide treatment and the need for further specialist intervention. <ul><li>Low molecular weight heparin (LMWH) and fondaparinux have been shown to reduce the risk of superficial vein thrombosis extension and recurrence.</li><li>Fondaparinux has also been shown to significantly reduce the risk of symptomatic venous thromboembolism and may be considered in people at <a class=\"topic-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/background-information/complications/\">increased risk</a> of a DVT or PE, for example those with superficial thrombus near the saphenofemoral junction.</li></ul></li><li><strong>Offer compression stockings </strong>(after <a class=\"topic-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/management/management-of-superficial-vein-thrombosis/#excluding-arterial-insufficiency\">excluding arterial insufficiency</a>).<ul><li>Many people will find the use of class 2 compression stockings too painful. Class 1 stockings or travel socks are a practical alternative and are less likely to compromise arterial circulation. </li><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/compression-stockings/\">Compression stockings</a> for detailed information on the use of compression stockings.</li></ul></li><li><strong>Provide written information on superficial vein thrombosis. </strong>Patient information is available from: <ul><li>The NHS website (<a data-hyperlink-id=\"2a83423e-ff79-4339-b49b-ab6e00a67a36\" href=\"http://www.nhs.uk/conditions/phlebitis/\">www.nhs.uk</a>).</li></ul></li></ul></li><li><strong>For people with recurrent superficial vein thrombosis</strong> <strong>with no obvious <a class=\"topic-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/background-information/causes-risk-factors/\">cause or risk factor</a>, </strong>consider investigating for a coagulation disorder.</li></ul><!-- end field e1991cb3-b9de-4280-83d1-0adf7b2d8235 --><!-- end item 006383ab-3443-4628-8e77-f0b9c19d6b50 -->","subChapters":[{"id":"b0511b35-fc57-5584-b5bf-cfa709bb02b2","slug":"excluding-arterial-insufficiency","fullItemName":"Excluding arterial insufficiency","depth":4,"htmlHeader":"<!-- begin field 56b5cdb3-ad8a-48a7-b303-ab4e014e4f25 --><h4>Excluding arterial insufficiency</h4><!-- end field 56b5cdb3-ad8a-48a7-b303-ab4e014e4f25 -->","summary":null,"htmlStringContent":"<!-- begin item 35011bdd-a1a7-4662-b8a9-ab4e014e4f05 --><!-- begin field 0850b1b9-4355-43c4-84f5-ab4e014e4f25 --><ul><li><strong>It is important to exclude arterial insufficiency before prescribing compression stockings. </strong>If arterial circulation is impaired, compression may further impair the arterial supply and result in pressure damage, limb ischaemia, and amputation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Joint Formulary Committee, 2019</a>].</li><li>Measurement of the ankle brachial pressure index (ABPI) is the most reliable way to detect arterial insufficiency. The absence of foot pulses may indicate arterial insufficiency, but palpation alone is not sufficient to rule this out [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">SIGN, 2010</a>].</li><li>The ABPI is the ratio of the ankle systolic blood pressure to the brachial systolic blood pressure and can be measured using a sphygmomanometer and a hand held Doppler device. If the ABPI is [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">SIGN, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Wounds UK, 2019</a>]:<ul><li>Less than 0.5 — severe arterial insufficiency is likely, and compression stockings are contraindicated. The person should be referred urgently for specialist vascular assessment. </li><li>Greater than 0.5 to less than 0.8 — arterial disease or mixed arterial/venous disease is likely. Compression should generally be avoided, but reduced compression can be used under specialist advice and with strict supervision. The person should be referred for specialist vascular assessment. </li><li>Between 0.8 and 1.3 — arterial disease is unlikely, and compression stockings are generally safe to wear.</li><li>Greater than 1.3 — high ABPI values may be due to arterial calcification, such as in some people with diabetes, rheumatoid arthritis, systemic vasculitis, atherosclerotic disease, and advanced chronic renal failure. For values above 1.5, the vessels are likely to be incompressible and the result cannot be relied on to guide clinical decisions. The person should be referred for specialist vascular assessment.</li></ul></li></ul><!-- end field 0850b1b9-4355-43c4-84f5-ab4e014e4f25 --><!-- end item 35011bdd-a1a7-4662-b8a9-ab4e014e4f05 -->","subChapters":[]},{"id":"7c45130b-7640-5ce3-8894-a29894f9b211","slug":"basis-for-recommendation-d5b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2b453a87-1f67-4df5-8dab-bb08ebb06986 --><h4>Basis for recommendation</h4><!-- end field 2b453a87-1f67-4df5-8dab-bb08ebb06986 -->","summary":null,"htmlStringContent":"<!-- begin item d5b17d9d-5e5b-479c-90fd-7fe7e06d7a40 --><!-- begin field 51d19d3e-6ea0-4ba2-a2a9-c5f86369ae47 --><p>These recommendations are largely based on a Cochrane Systematic Review on <em>Treatment for superficial thrombophlebitis of the leg</em> (search date: March 2017) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Di Nisio, 2018</a>], a Brazilian guideline <em>Guidelines for superficial venous thrombosis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Almeida, 2019</a>], a Canadian guideline <em>Superficial thrombophlebitis, superficial vein thrombosis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Thrombosis Canada, 2018</a>], and on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">BMJ, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Cosmi, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Scott, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">BMJ, 2018</a>].</p><h5>Referral if a serious underlying cause is suspected</h5><ul><li>This recommendation is based on what CKS considers to be good clinical practice.</li></ul><h5>Nonsteroidal anti-inflammatory drugs (NSAIDs)</h5><ul><li>A Cochrane systematic review found that when compared with placebo or topical treatments, oral NSAIDs could help prevent superficial vein thrombosis extension (where the clot moves further up the leg) and/or recurrence while effectively controlling local symptoms. However, the evidence was too limited and did not inform clinical practice about the effects of NSAIDs on venous thromboembolism (VTE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Di Nisio, 2018</a>]. Nevertheless, oral NSAIDs are commonly prescribed in the UK to manage local symptoms of superficial vein thrombosis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Cosmi, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Scott, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">BMJ, 2018</a>]. </li><li>Weak evidence suggests that topical NSAIDs improve local symptoms of superficial vein thrombosis compared with placebo, but there were no data on the effects of topical NSAIDs on VTE and superficial vein thrombosis extension. However, topical NSAIDs are very widely used for simple analgesia in other indications, and there is less risk of adverse effects with topical NSAIDs than with oral preparations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Di Nisio, 2018</a>]. </li></ul><h5>Paracetamol</h5><ul><li>CKS found no trials on the analgesic effect of paracetamol for superficial vein thrombosis, but it is very widely used for simple analgesia in other indications.</li></ul><h5>Self-care advice</h5><ul><li>These recommendations are extrapolated from the National Institute for health and Care Excellence (NICE) guideline <em>Venous thromboembolic diseases: diagnosis, management and thrombophilia testing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">NICE, 2015</a>] and on what CKS considers to be good clinical practice. <ul><li>Keeping the leg elevated when sitting may improve venous blood flow and reduce swelling.</li><li>Immobility can temporarily increase the likelihood of deep vein thrombosis (DVT) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">NICE, 2015</a>]. CKS advises remaining active to reduce this risk.</li></ul></li></ul><h5>Antibiotic treatment</h5><ul><li>Antibiotic treatment is generally not indicated in people with superficial vein thrombosis unless there are signs of infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">BMJ, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">BMJ, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Thrombosis Canada, 2018</a>].</li><li>CKS recommends admission for people with infected thrombophlebitis who are ill or are at risk of serious illness, because they may require treatment with intravenous antibiotics. Although infected thrombophlebitis most commonly presents as a localized infection, it may spread (especially in this group of people) and become life-threatening.</li></ul><h5>Referral to a vascular service</h5><ul><li>This recommendation is extrapolated from the NICE guideline <em>Varicose veins in the legs: The diagnosis and management of varicose veins </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">National Clinical Guideline Centre, 2013</a>]. NICE based these recommendations on evidence from two prognostic reviews, although the evidence was limited in terms of quality and consistency. They are also based on the expert opinion of the NICE guideline development group (GDG). <ul><li>NICE recommends referral based on evidence that DVT is present in 20% of legs with superficial vein thrombosis.</li><li>Referral is usually recommended for symptom control and to prevent disease progression<em>.</em></li><li>NICE recommends referral to a vascular service, where a full clinical and duplex Doppler ultrasound assessment, as well as a full range of treatments, can be provided.<ul><li>The NICE GDG highlighted that the location of this service can be decided locally, with some of the service being delivered in primary care where skills and equipment are available.</li><li>The GDG acknowledged that people referred would not necessarily receive interventional treatment but could still benefit from the expertise available from vascular specialists. </li></ul></li></ul></li></ul><h5>Low molecular weight heparin (LMWH) and fondaparinux</h5><ul><li>A Cochrane systematic review found that when compared with placebo, LMWH reduced superficial vein thrombosis extension or recurrence with no effect on symptomatic VTE or major bleeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Di Nisio, 2018</a>].</li><li>Fondaparinux sodium is a synthetic pentasaccharide that inhibits activated factor X [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Joint Formulary Committee, 2019</a>]. In the Cochrane systematic review, one large study, accounting for half of the participants included in the review, showed that treatment with fondaparinux for 45 days was associated with a significant reduction in symptomatic VTE (where symptoms indicate there is a VTE), superficial vein thrombosis extension, and recurrence of superficial vein thrombosis compared with placebo. Major bleeding was infrequent in both groups. In one study in people with superficial vein thrombosis at high risk of recurrent thromboembolic events, fondaparinux was associated with a non-significant reduction of symptomatic VTE compared with rivaroxaban. There were no major bleeding events in either group [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Di Nisio, 2018</a>].</li><li>Anticoagulation to prevent DVT or pulmonary embolism (PE) is especially warranted in people considered to be at increased risk of VTE,<strong> </strong>for example when the superficial thrombus is near the saphenofemoral junction or when it is 5 cm or greater in length [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Cosmi, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">BMJ, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Thrombosis Canada, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Almeida, 2019</a>].</li></ul><h5>Compression stockings</h5><ul><li>A Cochrane systematic review found that surgical treatment and wearing elastic stockings were associated with a lower rate of VTE and progression of superficial vein thrombosis compared with elastic stockings alone [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Di Nisio, 2018</a>].</li><li>However, compression stockings are commonly recommended for relieving swelling and providing comfort [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">BMJ, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Cosmi, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">BMJ, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Thrombosis Canada, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">Almeida, 2019</a>]. </li></ul><h5>Providing written information on superficial vein thrombosis</h5><ul><li>This recommendation is based on what CKS considers to be good clinical practice.</li></ul><h5>Managing people with recurrent superficial vein thrombosis​​​​​​​ with no obvious cause/risk factor </h5><ul><li>This recommendation is extrapolated from the NICE guideline <em>Venous thromboembolic diseases: diagnosis, management and thrombophilia testing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/superficial-vein-thrombosis-superficial-thrombophlebitis/references/\">NICE, 2015</a>], which recommends thrombophilia testing for people who have unprovoked DVT or PE. </li></ul><!-- end field 51d19d3e-6ea0-4ba2-a2a9-c5f86369ae47 --><!-- end item d5b17d9d-5e5b-479c-90fd-7fe7e06d7a40 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}